InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
InDevR Raises $9 Million in Series B Financing and Partners [...]
InDevR Raises $9 Million in Series B Financing and Partners [...]
InDevR Raises $7 million in Series A Financing with Adjuvant [...]
[Press Release] InDevR launches a new product that could shave weeks [...]
I&L showcased InDevR products at the World Vaccine Congress in [...]
InDevR licenses Mount Sinai influenza antibodies for VaxArray neuraminidase potency [...]